LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | BI-2536 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 1511 | 5505 | 0.2744 | -0.0381 |
BT-20 | BMS345541 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5506 | 5505 | 1.0001 | 1.0002 |
BT-20 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 1617 | 5505 | 0.2938 | -0.0104 |
BT-20 | GDC-0980 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 2054 | 5505 | 0.3732 | 0.1032 |
BT-20 | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5821 | 5505 | 1.0573 | 1.0820 |
BT-20 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5393 | 5505 | 0.9795 | 0.9707 |
BT-20 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5535 | 5505 | 1.0054 | 1.0078 |
BT-20 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5203 | 5505 | 0.9452 | 0.9215 |
BT-20 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5235 | 5505 | 0.9509 | 0.9297 |
BT-20 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 1796 | 5505 | 0.3263 | 0.0361 |
BT-20 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2386 | 5505 | 0.4334 | 0.1894 |
BT-20 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4303 | 5505 | 0.7816 | 0.6875 |
BT-20 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5119 | 5505 | 0.9298 | 0.8996 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5436 | 5505 | 0.9875 | 0.9821 |
BT-20 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4087 | 5505 | 0.7425 | 0.6315 |
BT-20 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4754 | 5505 | 0.8635 | 0.8047 |
BT-20 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 3685 | 5505 | 0.6694 | 0.5270 |
BT-20 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5301 | 5505 | 0.9629 | 0.9469 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5192 | 5505 | 0.9430 | 0.9185 |
BT-20 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5125 | 5505 | 0.9310 | 0.9013 |
BT-20 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4875 | 5505 | 0.8855 | 0.8361 |
BT-20 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5995 | 5505 | 1.0889 | 1.1273 |
BT-20 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 1844 | 5505 | 0.3351 | 0.0486 |
BT-20 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 1028 | 5505 | 0.1868 | -0.1636 |
BT-20 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5492 | 5505 | 0.9976 | 0.9966 |